Gamma-aminobutyric acid type A receptor alpha-6 beta-2 gamma-2 subunit complex (GABAA receptor α6β2γ2)

The GABAA receptor α6β2γ2 is a specific subtype of the ionotropic gamma-aminobutyric acid type A receptor, a pentameric ligand-gated chloride channel that mediates fast inhibitory neurotransmission in the central nervous system [1, 6]. This particular isoform is characterized by the presence of the α6 subunit, which is predominantly expressed in the granule cells of the cerebellum and the cochlear nucleus, as well as in the trigeminal ganglia [1, 11]. Unlike the more common α1, α2, or α3-containing GABAA receptors, α6-containing receptors are insensitive to classical benzodiazepines like diazepam due to a specific arginine residue in the α6 subunit [6, 17]. They play a critical role in sensorimotor gating, motor coordination, and the processing of sensory information [2, 11]. Dysregulation of α6-containing receptors has been implicated in conditions such as tinnitus, migraine, trigeminal neuralgia, and various neuropsychiatric disorders including schizophrenia [4, 9, 11]. Therapeutic strategies focus on positive allosteric modulators (PAMs) that selectively target the α6 subunit to alleviate symptoms without the sedative side effects typically associated with broad-spectrum GABAA receptor modulation [2, 9].

Other names

α6β2γ2 GABAA receptorGABRA6-containing GABAA receptorAlpha-6 beta-2 gamma-2 GABA-A receptorGABA(A) receptor subunit alpha-6/beta-2/gamma-2

Positive allosteric modulation of the chloride channel to enhance GABA-induced inhibitory currents; selective ligands often target the α+β- interface or the benzodiazepine binding site (despite diazepam insensitivity).